S&P ASX All Technology

3,113.80

0.00%

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
ETFs
USA
AMEX
Meet Kevin Pricing Power ETF (PP)
Meet Kevin Pricing Power ETF (PP) News

PP

Meet Kevin Pricing Power... (PP)

Meet Kevin Pricing Power ETF

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:PP

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
10/10/2008	04:03	Edgar (US Regulatory)	Statement of Beneficial Ownership (SC 13D)	AMEX:PP	Meet Kevin Pricing Power ETF
06/10/2008	23:30	Marketwired	Pipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7th	AMEX:PP	Meet Kevin Pricing Power ETF
19/09/2008	22:30	Marketwired	Pipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and Re	AMEX:PP	Meet Kevin Pricing Power ETF
30/08/2008	07:01	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A)	AMEX:PP	Meet Kevin Pricing Power ETF
19/08/2008	22:54	Marketwired	Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis	AMEX:PP	Meet Kevin Pricing Power ETF
19/08/2008	22:30	Marketwired	Pipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York City	AMEX:PP	Meet Kevin Pricing Power ETF
15/08/2008	06:49	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)	AMEX:PP	Meet Kevin Pricing Power ETF
15/08/2008	06:18	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
15/08/2008	03:39	Marketwired	Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results	AMEX:PP	Meet Kevin Pricing Power ETF
12/08/2008	22:27	Marketwired	Pipex Pharmaceuticals to Present at the Noble Financial Equity Conference	AMEX:PP	Meet Kevin Pricing Power ETF
15/07/2008	22:40	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)	AMEX:PP	Meet Kevin Pricing Power ETF
15/07/2008	08:45	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:PP	Meet Kevin Pricing Power ETF
10/07/2008	04:48	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
09/07/2008	22:38	Marketwired	Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Or	AMEX:PP	Meet Kevin Pricing Power ETF
09/07/2008	07:16	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
09/07/2008	05:54	Marketwired	Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in Dry	AMEX:PP	Meet Kevin Pricing Power ETF
08/07/2008	21:41	Marketwired	Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer	AMEX:PP	Meet Kevin Pricing Power ETF
20/05/2008	23:00	Marketwired	Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules	AMEX:PP	Meet Kevin Pricing Power ETF
17/05/2008	00:59	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
16/05/2008	07:13	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)	AMEX:PP	Meet Kevin Pricing Power ETF
16/05/2008	06:36	Marketwired	Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results	AMEX:PP	Meet Kevin Pricing Power ETF
13/05/2008	23:05	Marketwired	Pipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15	AMEX:PP	Meet Kevin Pricing Power ETF
12/05/2008	23:23	Marketwired	Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)	AMEX:PP	Meet Kevin Pricing Power ETF
07/05/2008	23:00	Marketwired	Pipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's Disease	AMEX:PP	Meet Kevin Pricing Power ETF
02/05/2008	22:38	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF
30/04/2008	05:35	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A)	AMEX:PP	Meet Kevin Pricing Power ETF
21/04/2008	22:02	Marketwired	Pipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for Fibromyalgia	AMEX:PP	Meet Kevin Pricing Power ETF
19/04/2008	07:13	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	AMEX:PP	Meet Kevin Pricing Power ETF
16/04/2008	01:12	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)	AMEX:PP	Meet Kevin Pricing Power ETF
02/04/2008	04:49	Edgar (US Regulatory)	Pipex Pharmaceuticals, Inc. - Current report filing (8-K)	AMEX:PP	Meet Kevin Pricing Power ETF